Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2023

  1. Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry

    International Journal of Cardiology, Vol. 370, pp. 279-286

2022

  1. Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

    ESC Heart Failure, Vol. 9, Núm. 6, pp. 4209-4218

  2. Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, Núm. 4, pp. 469-477

2020

  1. Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry

    ESC Heart Failure, Vol. 7, Núm. 2, pp. 727-736